561
Views
18
CrossRef citations to date
0
Altmetric
Articles

The Blue Lotus Flower (Nymphea caerulea) Resin Used in a New Type of Electronic Cigarette, the Re-Buildable Dripping Atomizer

, B.S. ORCID Icon, , B.S., , Ph.D., , Ph.D., , Ph.D. & , Ph.D.
Pages 175-181 | Received 13 Nov 2016, Accepted 29 Dec 2016, Published online: 07 Mar 2017

References

  • Bhattacharya, S. K., R. Bose, P. Ghosh, V. J. Tripathi, A. B. Ray, and B. Dasgupta. 1978. Psychopharmacological studies on (–)-nuciferine and its Hofmann degradation product atherosperminine. Psychopharmacology (Berl) 59 (1):29–33. doi:10.1007/BF00428026.
  • Breland, A., E. Soule, A. Lopez, C. Ramôa, A. El-Hellani, and T. Eissenberg. 2016. Electronic cigarettes: What are they, and what do they do? Annals of the New York Academy of Sciences, Advance online publication. doi:10.1111/nyas.12977.
  • Emboden, W. 1989. The sacred journey in dynastic Egypt: Shamanistic trance in the context of the narcotic water lily and the mandrake. Journal of Psychoactive Drugs 21 (1):61–75. doi:10.1080/02791072.1989.10472144.
  • Farrell, M. S., J. D. McCorvy, X. P. Huang, D. J. Urban, K. L. White, P. M. Giguere, A. K. Doak, A. I. Bernstein, K. A. Stout, S. M. Park, R. M. Rodriguiz, B. W. Gray, W. S. Hyatt, A. P. Norwood, K. A. Webster, B. M. Gannon, G. W. Miller, J. H. Porter, B. K. Shoichet, W. E. Fantegrossi, W. C. Wetsel, and B. L. Roth. 2016. In vitro and in vivo characterization of the alkaloid nuciferine. PLOS One 11 (3):e0150602. doi:10.1371/journal.pone.0150602.
  • Gottlieb, S. 2000. FDA committee recommends approval for Viagra rival. The BMJ 320 (6):1094.
  • LeWitt, P. A. 2004. Subcutaneously administered apomorphine: Pharmacokinetics and metabolism. Neurology 62 (Suppl. 4):S8–S11. doi:10.1212/WNL.62.6_suppl_4.S8.
  • Millan, M. J., L. Maiofiss, D. Cussac, V. Audinot, J. A. Boutin, and A. Newman-Tancredi. 2002. Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes. Journal of Pharmacology and Experimental Therapeutics 303 (2):791–804. doi:10.1124/jpet.102.039867.
  • Okun, M. S., and K. D. Foote. 2010. Parkinson’s disease DBS: What, when, who and why? The time has come to tailor DBS targets. Expert Review of Neurotherapeutics 10 (12):1847–57. doi:10.1586/ern.10.156.
  • Peace, M. R., T. R. Baird, N. Smith, C. E. Wolf, J. L. Poklis, and A. Poklis. 2016a. Concentration of nicotine and glycols in 27 electronic cigarette formulations. Journal of Analytical Toxicology 40 (6):403–07. doi:10.1093/jat/bkw037.
  • Peace, M. R., J. W. Stone, J. L. Poklis, J. B. M. Turner, and A. Poklis. 2016b. Analysis of a commercial marijuana e-cigarette formulation. Journal of Analytical Toxicology 40 (5):374–78. doi:10.1093/jat/bkw021.
  • Poklis, J. L., S. A. Raso, K. A. Alford, A. Poklis, and M. R. Peace. 2015. Analysis of 25I-NBOMe, 25B-NBOMe, 25C-NBOMe and other dimethoxyphenyl-N-[(2-methoxyphenyl) methyl] ethanamine derivatives on blotter paper. Journal of Analytical Toxicology 39 (8):617–23. doi:10.1093/jat/bkv073.
  • Ribarič, S. 2012. The pharmacological properties and therapeutic use of apomorphine. Molecules 17 (5):5289–309. doi:10.3390/molecules17055289.
  • Scherkl, R., A. Hashem, and H.-H. Frey. 1990. Apomorphine-induced emesis in the dog-routes of administration, efficacy and synergism by naloxone. Journal of Veterinary Pharmacology and Therapeutics 13 (2):154–58. doi:10.1111/j.1365-2885.1990.tb00763.x.
  • Schwab, R. S., L. V. Amador, and J. Y. Lettvin. 1951. Apomorphine in Parkinson’s disease. Transactions of the American Neurological Association 56:251–53.
  • Wang, X., W. S. Cheang, H. Yang, L. Xiao, B. Lai, M. Zhang, J. Ni, Z. Luo, Z. Zhang, Y. Huang, and N. Wang. 2015. Nuciferine relaxes rat mesenteric arteries through endothelium-dependent and -independent mechanisms. British Journal of Pharmacology 172 (23):5609–18. doi:10.1111/bph.13021.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.